Liz Crittle-Hollow
Vice President, Investor Relations
Replay available
Tempus AI, Inc. (NASDAQ: TEM) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
Founder & CEO
Chief Financial Officer
Analyst, Needham & Company
Analyst, TD Calvin
Analyst, J.P. Morgan
Analyst, Bank of America
Analyst, Blue Capital Markets
Analyst, Piper Sandler
Analyst, Stifel
Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the Tempus AI third quarter 2025 financial results conference call. All lines has been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press the star one. I would now like to turn the conference over to Liz Krita Hollow, Vice President, Investor Relations. You may begin. Thank you. Good afternoon and welcome to Tempest's third quarter 2025 conference call. This afternoon, Tempest released results for the quarter ended September 30th, 2025. The press release, an overview of the quarter, and our latest presentation are available on our IR website. Joining me today from Tempest are Eric Levkovsky, founder and CEO of Tempest, and Jim Rogers, CFO. Before we begin, I would like to remind you that during this call, management may make forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For discussion of these risks, please refer to our 10-K and other subsequent filings with the SEC. During the call, we will discuss non-GAAP financial measures, which are not prepared in accordance with generally accepted accounting principles. Definitions of these non-GAAP financial measures, along with reconciliation and more directly comparable GAAP financial measures, are included in our earnings release and is available on our IR page. I would now like to turn the call over to Eric. Thank you. Q3 was a great quarter all around. Our genomics volume came in super strong with...